Thursday, October 1, 2026 - Medication prices are surging across Iran, with some treatments becoming increasingly difficult to find as a U.S. naval blockade, sanctions and the wider war disrupt pharmaceutical supplies.
Some medicines have more than tripled in price, while Iran's currency has fallen sharply and inflation continues to squeeze household budgets.
Although Iran produces more than 80% of its medicines domestically, pharmaceutical manufacturers still depend heavily on imported raw materials.
Disrupted sea shipments have forced importers toward more expensive alternatives, while financial restrictions make it harder for companies to process payments and maintain reliable supply chains. Reports also indicate that more than 40 pharmaceutical factories have been damaged during the conflict.
The pressure is increasingly being felt by patients at pharmacies, particularly those needing long-term or specialised treatment. Prices for some kidney-dialysis medicines have risen by nearly 350%, while pharmacists report shortages of essential drugs, including medicines for serious illnesses.
With families already struggling with rising food and living costs, the growing price and availability of medicine are turning healthcare into an increasingly urgent financial burden.
0 Comments